Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion type Assertion NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_head.
- NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion description "[In the meta-analysis, the summary odds ratios (ORs) for head and neck cancer were 1.23 [95% confidence interval (95% CI), 1.06-1.42] for the GSTM1 null genotype, 1.17 (95% CI, 0.98-1.40) for the GSTT1 null genotype, 1.10 (95% CI, 0.92-1.31) for carrying the GSTP1 Val105 allele, and 1.35 (95% CI, 0.95-1.82) for carrying the CYP1A1 Val462 allele.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_provenance.
- NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion evidence source_evidence_literature NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_provenance.
- NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion SIO_000772 14693745 NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_provenance.
- NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion wasDerivedFrom befree-20140225 NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_provenance.
- NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_assertion wasGeneratedBy ECO_0000203 NP228599.RASyflRLfIFDoqJ6s56h_68DEiILF-j3TKjPp-7hpKF_I130_provenance.